Phase III Randomized Study of Letrozole Versus Placebo in Women With Resected Breast Cancer After Completion of Treatment with Adjuvant Tamoxifen
Phase III Randomized Study of Exemestane Versus Tamoxifen in Postmenopausal Women With Primary Breast Cancer Who Have Already Received 2-3 Years of Adjuvant Tamoxifen After Potentially Curable Surgery
Home
Search
